Article
A Cellular Conformation-Based Screen for Androgen Receptor Inhibitors
27 Jun 2008
Abstract excerpt
The androgen receptor (AR), a member of the steroid nuclear receptor family of transcription factors, regulates a wide range of physiological processes. Androgen signaling is also associated with numerous human diseases, including prostate cancer. All current antiandrogen therapies reduce ligand access to AR, whether by competitive antagonism or inhibition of androgen production, but are limited by acquired...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
